1. Efficacy and Safety of Subcutaneous Belimumab in Anti–Double‐Stranded DNA–Positive, Hypocomplementemic Patients With Systemic Lupus Erythematosus. Issue 8 (15th June 2018) Authors: Doria, A.; Stohl, W.; Schwarting, A.; Okada, M.; Scheinberg, M.; van Vollenhoven, R.; Hammer, A. E.; Groark, J.; Bass, D.; Fox, N. L.; Roth, D.; Gordon, D. Journal: Arthritis & rheumatology Issue: Volume 70:Issue 8(2018) Page Start: 1256 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. LB0001 Efficacy and Safety of Subcutaneous Belimumab plus Standard Care in Patients with Systemic Lupus Erythematosus (SLE) with Low Complement and Positive Anti-DSDNA. (15th July 2016) Authors: Doria, A.; Stohl, W.; Schwarting, A.; Okada, M.; Scheinberg, M.; van Vollenhoven, R.; Hammer, A.E.; Groark, J.; Bass, D.; Fox, N.L.; Roth, D.; Gordon, D. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 70 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. SAT0158 EFFICACY AND SAFETY OF FILGOTINIB IN METHOTREXATE-NAÏVE PATIENTS WITH RHEUMATOID ARTHRITIS: FINCH 3 52-WEEK RESULTS. (2nd June 2020) Authors: Westhovens, R.; Rigby, W.; Van der Heijde, D.; Ching, D.; Stohl, W.; Kay, J.; Chopra, A.; Bartok, B.; Matzkies, F.; Yin, Z.; Guo, Y.; Tasset, C.; Sundy, J.; Jahreis, A.; Mozaffarian, N.; Messina, O.; Landewé, R. B. M.; Atsumi, T.; Burmester, G. R. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 1019 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗